Viavi Solutions CEO Oleg Khaykin sells $6.8m in company stock

VIAVI CEO Oleg Khaykin sold 124,790 shares on May 5, 2026 for about $6.8 million, including 104,552 direct shares at $54.61 and 20,238 indirect spouse-held shares at $54.77. The company also recently beat fiscal Q3 2026 expectations, posting EPS of $0.27 vs. $0.23 consensus and revenue of $406.8 million vs. $393.8 million. The article additionally highlights the launch of the CyberFlood CF1000 Appliance, a 400G security and application performance test platform.

Analysis

The insider sale is a sentiment signal, but the bigger tell is timing: monetization into a sharp rerate usually means management sees the easy multiple expansion as largely captured. That matters because the name now needs follow-through from fundamentals, not just a “beat-and-raise” narrative; when a stock has already compounded this hard, any deceleration in bookings or gross margin leverage can compress the multiple faster than the earnings can grow.

The second-order effect is on holder behavior, not just fundamentals. A large CEO sale can act as a catalyst for quant and momentum de-risking, especially in a name that has likely become crowded after a multi-bagger run; even a 5-10% air pocket can force short-term traders out and create a self-reinforcing reset. The company’s new product launch helps the medium-term story, but hardware validation products typically matter more for pipeline credibility than near-term P&L, so the market may be overpricing immediate monetization.

From a competitive standpoint, the strength in test/validation demand likely spills into adjacent networking and security infrastructure vendors, but it also invites scrutiny on whether customers are pulling forward capex ahead of a more normal demand backdrop. If enterprise and hyperscale spending re-accelerates broadly, VIAV can continue to work; if not, the stock is vulnerable to mean reversion because expectations are now elevated and insider behavior suggests the risk/reward is becoming less asymmetric.

The contrarian read is that the stock may not be expensive on next year’s earnings if the recent upward estimate revisions persist. The right framing is not “sell because insider sold,” but “own only if the earnings revision cycle stays positive for another 1-2 quarters”; absent that, insider selling after a 500% run is more consistent with late-cycle distribution than with durable underappreciation.

Key Decisions for Investors

• Trim VIAV into strength over the next 1-2 sessions; use any post-open rally as a liquidity event, with a stop to re-add only if guidance and estimates keep rising for another quarter. Risk/reward favors harvesting gains after a 500% run rather than paying up for continuation.
• For tactical shorts, consider a small put spread in VIAV 1-3 months out, targeting a 10-15% downside reset if momentum breaks and insider-sale headlines trigger multiple compression. Keep sizing modest given the positive estimate revision backdrop.
• Pair trade: long a diversified networking/hyperscale beneficiary basket vs. short VIAV for 1-2 months, betting that broad capex demand captures the upside while VIAV’s rerate is more fragile. This isolates the “same-theme, cleaner valuation” spread.
• If already long, sell covered calls 1-2 months out to monetize elevated implied volatility and reduce gap risk from post-earnings or after-hours digestion. This is a good fit if the goal is to keep exposure but cap downside after the insider overhang.
• Set a re-entry trigger only on a pullback to prior breakout levels with continued analyst revisions; absent that, the stock’s setup is better for trading than for fresh long initiation.